US equities
|
MU
$896.07
▼-0.98%
NVDA
$216.47
▼-0.29%
SPCX
$147.79
▼-0.11%
AAPL
$339.50
▼-1.00%
TSLA
$373.71
▲+1.54%
META
$694.25
▼-1.59%
AMZN
$262.63
▲+0.07%
SNDK
$1,365.38
▼-0.42%
MU
$896.07
▼-0.98%
NVDA
$216.47
▼-0.29%
SPCX
$147.79
▼-0.11%
AAPL
$339.50
▼-1.00%
TSLA
$373.71
▲+1.54%
META
$694.25
▼-1.59%
AMZN
$262.63
▲+0.07%
SNDK
$1,365.38
▼-0.42%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Deuterated Psychedelics
Recent news which mentions Deuterated Psychedelics
Cybin Inc's Two Deuterated Psychedelic Molecules Achieve Positive Topline Clinical Results
January 09, 2024
Tickers
CYBN
NEWS
Tags
Global
Management
Benzinga
From
Benzinga
Cybin's Novel Psilocybin Topline Data: 79% Remission In Major Depression Symptoms, What's Next?
December 03, 2023
Tickers
CYBN
Tags
News
Next/Generation Psychedelics
Market News
From
Benzinga
Cybin Completes Dosing In Phase 2 Study Of CYB003 For Major Depressive Disorder Treatment
October 03, 2023
Tickers
CYBN
Tags
major depressive disorder
Management
Benzinga
From
Benzinga
Cybin's Intellectual Powerhouse Grows With New US Patent Covering Deuterated 5-MeO-DMT
September 05, 2023
Tickers
CYBN
DMTTF
Tags
DMTTF
Benzinga
Markets
From
Benzinga